These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 4278759

  • 21. Viruses, tumours, and immune deficiency.
    Purtilo DT.
    Lancet; 1982 Mar 20; 1(8273):684. PubMed ID: 6121992
    [No Abstract] [Full Text] [Related]

  • 22. Cell-virus interaction in virus-induced animal tumours.
    Harris RJ.
    Proc R Soc Med; 1970 Apr 20; 63(4):344-5. PubMed ID: 4315112
    [No Abstract] [Full Text] [Related]

  • 23. [Etiology of cancer].
    Pérez Tamayo R.
    Prensa Med Mex; 1974 Mar 20; 39(3-4):189-201. PubMed ID: 4409498
    [No Abstract] [Full Text] [Related]

  • 24. [Immunosuppression mechanism affecting the development of neoplasms].
    Rupniewska ZM, Kurowska M.
    Pol Tyg Lek; 1980 Mar 24; 35(12):455-7. PubMed ID: 6966796
    [No Abstract] [Full Text] [Related]

  • 25. Current aspects of tumor immunology. Preface and introduction.
    Weiss DW.
    Isr J Med Sci; 1973 Mar 24; 9(3):205-16. PubMed ID: 4575649
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Immune surveillance in neoplasms].
    Schneeweiss U.
    Z Exp Chir; 1974 Mar 24; 7(4):204-15. PubMed ID: 4440030
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [The immunity mechanisms, for or against the cancer patient?].
    Mathé G.
    Nouv Presse Med; 1973 Mar 03; 2(9):553-5. PubMed ID: 4574115
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. "Immunostaging" as a guideline to immunotherapy in malignancy.
    Ablin RJ, Guinan PD, Bruns GR, Bush IM.
    Curr Ther Res Clin Exp; 1974 Aug 03; 16(8):765-8. PubMed ID: 4217242
    [No Abstract] [Full Text] [Related]

  • 40. Immune surveillance and tumor defense mechanisms.
    von Kleist S.
    Pathol Res Pract; 1980 Dec 03; 170(4):289-97. PubMed ID: 7012813
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.